These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22811504)

  • 1. What works and in whom? A simple, easily applied, evidence-based approach to guidelines for statin therapy.
    Ridker PM
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):592-3. PubMed ID: 22811504
    [No Abstract]   [Full Text] [Related]  

  • 2. Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side Effects.
    Peto R; Collins R
    Circulation; 2018 Oct; 138(15):1499-1501. PubMed ID: 30354509
    [No Abstract]   [Full Text] [Related]  

  • 3. MY APPROACH to the Patient With Memory Loss Who Needs a Statin.
    Watson KE; Sallam T
    Trends Cardiovasc Med; 2017 Feb; 27(2):158-159. PubMed ID: 28107839
    [No Abstract]   [Full Text] [Related]  

  • 4. Routine CAC-scoring prior to initiation of statin therapy - a European perspective.
    Mahabadi AA; Nasir K; Rassaf T
    Eur J Prev Cardiol; 2019 Sep; 26(14):1559-1561. PubMed ID: 30913900
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 6. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on lipids and C-reactive protein in acute and chronic coronary heart disease.
    Jones PH
    Tex Heart Inst J; 2010; 37(3):307-8. PubMed ID: 20548807
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 10. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics.
    Mikhailidis DP; Athyros VG
    Nat Rev Cardiol; 2014 Feb; 11(2):72-4. PubMed ID: 24366071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Quality Statin Trials Support the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines After the HOPE-3 Trial (Heart Outcomes Prevention Evaluation-3): MESA (The Multiethnic Study of Atherosclerosis).
    Mortensen MB; Budoff M; Li D; Nasir K; Blaha MJ; Sandfort V; Jose Rodriguez C; Ouyang P; Falk E
    Circulation; 2017 Nov; 136(19):1863-1865. PubMed ID: 28634218
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 15. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
    Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of persistent mixed dyslipidemia after statin initiation warrants combination therapy.
    Boden WE; McGovern ME
    Am J Cardiol; 2009 Dec; 104(12):1695-6. PubMed ID: 19962477
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
    Davidson MH
    Nat Rev Cardiol; 2011 Aug; 8(10):543-4. PubMed ID: 21808273
    [No Abstract]   [Full Text] [Related]  

  • 19. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.